94911-63-4

Usage

Uses

Used in Fragrance Industry:
Butanoic acid, 4-[bis(phenylmethyl)amino]-, ethyl ester is used as a fragrance ingredient for its distinctive fruity and floral scent. It adds depth and complexity to perfumes and other scented products, enhancing the overall olfactory experience.
Used in Food Industry:
In the food industry, Butanoic acid, 4-[bis(phenylmethyl)amino]-, ethyl ester is used as a flavoring agent. Its unique aroma profile contributes to the development of flavors in various food products, providing a pleasant taste and aroma that can enhance consumer appeal.
Safety Precautions:
It is important to handle Butanoic acid, 4-[bis(phenylmethyl)amino]-, ethyl ester with care due to its potential to cause skin and eye irritation. Additionally, it may be harmful if swallowed or inhaled, so proper safety measures should be taken during its use and storage.

Upstream product

• 7425-53-8 ethyl 4-iodobutyrate 
• 103-49-1 dibenzylamine 
• 2969-81-5 Ethyl 4-bromobutyrate 

Downstream Products

• 106518-44-9 N,N-dibenzyl-γ-amino-n.butyric acid 
• 1087312-00-2 1-[1-(4-dibenzylamino-butyryl)-piperidin-4-yl]-1,3-dihydro-benzoimidazol-2-one 
• 1455037-19-0 5-(dibenzylamino)-2-methylpentan-2-ol 
• 1089274-81-6 4-(dibenzylamino)butanal 
• 25472-60-0 1H-Pyrrol-2,3-dicarbonsaeure-diethylester 
• 5959-36-4 ethyl 4-aminobutyrate 

Relevant academic research and scientific papers

MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS

Provided herein are antibacterial compounds, wherein the compounds in some embodiments have broad spectrum bioactivity. In various embodiments, the compounds act by inhibition of bacterial type 1 signal peptidase (SpsB), an essential protein in bacteria. Pharmaceutical compositions and methods for treatment using the compounds described herein are also provided.

Novel indazoles for the treatment and prophylaxis of respiratory syncytial virus infection

The invention provides novel compounds having the general formula: wherein R1, R2, R3, R4, R5, R7, A1, A2 and A3 are as described herein, compositions including the compounds and methods of using the compounds.

Novel indazoles for the treatment and prophylaxis of respiratory syncytial virus infection

The invention provides novel compounds having the general formula: wherein R1, R2, R3, R4, R5, R7, A1, A2 and A3 are as described herein, compositions including the compounds and methods of using the compounds.

NOVEL INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION

The invention provides novel compounds having the general formula: formula (I) wherein R1, R2, R3, R4, R5, R7, A1, A2 and A3 are as described herein, compositions including the compounds and methods of using the compounds.

Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans

The Invention relates to compounds having an antiparasitic activity, and to their use as a drug, in particular as a drug for the prevention and/or treatment of parasitic diseases caused by apicomplexans. The invention also relates to pharmaceutical compositions containing those compounds.

HETEROCYCLIC-NMDA ANTAGONISTS

The present invention is directed to a class of 3-phosphono-piperidine and pyrrolidine derivatives and their use as NMDA antagonists.

Synthesis of Ethyl 2,3-Bis(ethoxycarbonyl)-1H-pyrrole-1-propionate

Ethyl 2,3-bis(ethoxycarbonyl)-1H-pyrrole-1-propionate (7) can easily be obtained in high yields from ethyl 4-iodobutyrate (1) via reaction with dibenzylamine and diethyl oxalate, catalytic debenzylation to diethyl cis-2,3-pyrrolidinedicarboxylate (5), sub